Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Does the oncology community have a rejection bias when it comes to repurposed drugs?

Bishal Gyawali, Pan Pantziarka, Sergio Crispino, Gauthier Bouche

Published 16 Jan 2018

https://doi.org/10.3332/ecancer.2018.ed76

PDF

The OlympiAD trial: who won the gold?

Bishal Gyawali

Published 6 Dec 2017

https://doi.org/10.3332/ecancer.2017.ed75

PDF

Colorectal cancer: towards new challenges and concepts of preventive healthcare

Lidia Colace, Stefania Boccia, Ruggero De Maria, Ann Zeuner

Published 28 Nov 2017

https://doi.org/10.3332/ecancer.2017.ed74

PDF

When populism takes over the delivery of health care: Venezuela

Sunil Daryanani

Published 23 Nov 2017

https://doi.org/10.3332/ecancer.2017.ed73

PDF | Spanish

Can e-learning help you to connect compassionately? Commentary on a palliative care e-learning resource for India

Soumitra Shankar Datta, Sanjit Agrawal

Published 19 Oct 2017

https://doi.org/10.3332/ecancer.2017.ed72

PDF

Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments

Wim van Harten, Maarten J IJzerman

Published 11 Sep 2017

https://doi.org/10.3332/ecancer.2017.ed71

PDF

Breast density and impacts on health

Cheryl Cruwys, JoAnn Pushkin

Published 8 Aug 2017

https://doi.org/10.3332/ecancer.2017.ed70

PDF

Editorial: Childhood Cancer in sub-Saharan Africa

Donald Maxwell Parkin, Cristina Stefan

Published 28 Jul 2017

https://doi.org/10.3332/ecancer.2017.ed69

PDF

Personalising your health: an EU imperative

Denis Horgan

Published 11 Jul 2017

https://doi.org/10.3332/ecancer.2017.ed68

PDF

How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulation

Anthony James Hatswell

Published 27 Jun 2017

https://doi.org/10.3332/ecancer.2017.ed67

PDF

More from ecancer